These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 667800)

  • 1. Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra.
    Orjasaeter H; Fosså SD; Schjølseth SA; Fjaestad K
    Cancer; 1978 Jul; 42(1):287-95. PubMed ID: 667800
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma levels of CEA as a prognostic marker in carcinoma of urinary bladder.
    Alsabti EA; Saffo MH
    Urol Int; 1979; 34(5):387-92. PubMed ID: 494440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen and bladder carcinoma.
    Ionescu G; Romas NA; Ionascu L; Bennett S; Tannenbaum M; Veeneman RJ; Lattimer JK
    J Urol; 1976 Jan; 115(1):46-8. PubMed ID: 1107601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder.
    Jakse G; Rauschmeier H; Rosmanith P; Hofstädter F
    Urol Int; 1983; 38(3):121-5. PubMed ID: 6868210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biologic significance and clinical value of carcinoembryonic antigen in tissues in transitional cell carcinoma of the urinary tract].
    Yang SC
    Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):228-30, 254. PubMed ID: 2805992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of CEA assay in tissue, serum and urine in patients with transitional cell carcinoma of the bladder.
    Alampi G; Ronchi E; Galassi A; Soli M; Botteghi B; Bercovich E
    Arch Anat Cytol Pathol; 1985; 33(4):193-6. PubMed ID: 3904640
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
    Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
    Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
    Lanzafame S; Puzzo L; Di Naso C; Di Marco G; Ranno S; Minardi G
    Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Tumors of the urethra in men and women.
    Grabstald H
    Cancer; 1973 Nov; 32(5):1236-55. PubMed ID: 4757914
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas.
    Jautzke G; Altenaehr E
    Cancer; 1982 Nov; 50(10):2052-6. PubMed ID: 6751517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls.
    Guinan P; Ablin RJ; Sadoughi N; Bush IM
    J Surg Oncol; 1974; 6(2):127-31. PubMed ID: 4822898
    [No Abstract]   [Full Text] [Related]  

  • 14. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
    J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD; Makhlin NV
    Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
    Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
    J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
    Hering H; Hering FJ; Weidner W
    Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
    Jubert AV; Talbott TM; Maycroft TM
    Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.